1 Study Coverage 1.1 Pulmonary Surfactant Product Introduction 1.2 Global Pulmonary Surfactant Outlook 2017 VS 2022 VS 2028 1.2.1 Global Pulmonary Surfactant Sales in US$ Million for the Year 2017-2028 1.2.2 Global Pulmonary Surfactant Sales in Volume for the Year 2017-2028 1.3 United States Pulmonary Surfactant Outlook 2017 VS 2022 VS 2028 1.3.1 United States Pulmonary Surfactant Sales in US$ Million for the Year 2017-2028 1.3.2 United States Pulmonary Surfactant Sales in Volume for the Year 2017-2028 1.4 Pulmonary Surfactant Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Pulmonary Surfactant in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Pulmonary Surfactant Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Pulmonary Surfactant Market Dynamics 1.5.1 Pulmonary Surfactant Industry Trends 1.5.2 Pulmonary Surfactant Market Drivers 1.5.3 Pulmonary Surfactant Market Challenges 1.5.4 Pulmonary Surfactant Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Pulmonary Surfactant Market Segment by Type 2.1.1 Synthetic Pulmonary Surfactants 2.1.2 Animal Derived Surfactants 2.2 Global Pulmonary Surfactant Market Size by Type 2.2.1 Global Pulmonary Surfactant Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Pulmonary Surfactant Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Pulmonary Surfactant Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Pulmonary Surfactant Market Size by Type 2.3.1 United States Pulmonary Surfactant Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Pulmonary Surfactant Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Pulmonary Surfactant Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Pulmonary Surfactant Market Segment by Application 3.1.1 Hospital 3.1.2 laboratory 3.1.3 Others 3.2 Global Pulmonary Surfactant Market Size by Application 3.2.1 Global Pulmonary Surfactant Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Pulmonary Surfactant Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Pulmonary Surfactant Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Pulmonary Surfactant Market Size by Application 3.3.1 United States Pulmonary Surfactant Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Pulmonary Surfactant Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Pulmonary Surfactant Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Pulmonary Surfactant Competitor Landscape by Company 4.1 Global Pulmonary Surfactant Market Size by Company 4.1.1 Top Global Pulmonary Surfactant Manufacturers Ranked by Revenue (2021) 4.1.2 Global Pulmonary Surfactant Revenue by Manufacturer (2017-2022) 4.1.3 Global Pulmonary Surfactant Sales by Manufacturer (2017-2022) 4.1.4 Global Pulmonary Surfactant Price by Manufacturer (2017-2022) 4.2 Global Pulmonary Surfactant Concentration Ratio (CR) 4.2.1 Pulmonary Surfactant Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pulmonary Surfactant in 2021 4.2.3 Global Pulmonary Surfactant Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Pulmonary Surfactant Manufacturing Base Distribution, Product Type 4.3.1 Global Pulmonary Surfactant Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Pulmonary Surfactant Product Type 4.3.3 Date of International Manufacturers Enter into Pulmonary Surfactant Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Pulmonary Surfactant Market Size by Company 4.5.1 Top Pulmonary Surfactant Players in United States, Ranked by Revenue (2021) 4.5.2 United States Pulmonary Surfactant Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Pulmonary Surfactant Sales by Players (2020, 2021 & 2022) 5 Global Pulmonary Surfactant Market Size by Region 5.1 Global Pulmonary Surfactant Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Pulmonary Surfactant Market Size in Volume by Region (2017-2028) 5.2.1 Global Pulmonary Surfactant Sales in Volume by Region: 2017-2022 5.2.2 Global Pulmonary Surfactant Sales in Volume Forecast by Region (2023-2028) 5.3 Global Pulmonary Surfactant Market Size in Value by Region (2017-2028) 5.3.1 Global Pulmonary Surfactant Sales in Value by Region: 2017-2022 5.3.2 Global Pulmonary Surfactant Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Pulmonary Surfactant Market Size YoY Growth 2017-2028 6.1.2 North America Pulmonary Surfactant Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Pulmonary Surfactant Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Pulmonary Surfactant Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Pulmonary Surfactant Market Size YoY Growth 2017-2028 6.3.2 Europe Pulmonary Surfactant Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Pulmonary Surfactant Market Size YoY Growth 2017-2028 6.4.2 Latin America Pulmonary Surfactant Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Pulmonary Surfactant Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Pulmonary Surfactant Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Boehringer Ingelheim 7.1.1 Boehringer Ingelheim Corporation Information 7.1.2 Boehringer Ingelheim Description and Business Overview 7.1.3 Boehringer Ingelheim Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Boehringer Ingelheim Pulmonary Surfactant Products Offered 7.1.5 Boehringer Ingelheim Recent Development 7.2 AbbVie 7.2.1 AbbVie Corporation Information 7.2.2 AbbVie Description and Business Overview 7.2.3 AbbVie Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.2.4 AbbVie Pulmonary Surfactant Products Offered 7.2.5 AbbVie Recent Development 7.3 Lyomark Pharma 7.3.1 Lyomark Pharma Corporation Information 7.3.2 Lyomark Pharma Description and Business Overview 7.3.3 Lyomark Pharma Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Lyomark Pharma Pulmonary Surfactant Products Offered 7.3.5 Lyomark Pharma Recent Development 7.4 Tekzima (Noargen) 7.4.1 Tekzima (Noargen) Corporation Information 7.4.2 Tekzima (Noargen) Description and Business Overview 7.4.3 Tekzima (Noargen) Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Tekzima (Noargen) Pulmonary Surfactant Products Offered 7.4.5 Tekzima (Noargen) Recent Development 7.5 ONY Biotech 7.5.1 ONY Biotech Corporation Information 7.5.2 ONY Biotech Description and Business Overview 7.5.3 ONY Biotech Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.5.4 ONY Biotech Pulmonary Surfactant Products Offered 7.5.5 ONY Biotech Recent Development 7.6 Abbott 7.6.1 Abbott Corporation Information 7.6.2 Abbott Description and Business Overview 7.6.3 Abbott Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Abbott Pulmonary Surfactant Products Offered 7.6.5 Abbott Recent Development 7.7 Aviva Systems Biology 7.7.1 Aviva Systems Biology Corporation Information 7.7.2 Aviva Systems Biology Description and Business Overview 7.7.3 Aviva Systems Biology Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Aviva Systems Biology Pulmonary Surfactant Products Offered 7.7.5 Aviva Systems Biology Recent Development 7.8 LSBio 7.8.1 LSBio Corporation Information 7.8.2 LSBio Description and Business Overview 7.8.3 LSBio Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.8.4 LSBio Pulmonary Surfactant Products Offered 7.8.5 LSBio Recent Development 7.9 Biomatik 7.9.1 Biomatik Corporation Information 7.9.2 Biomatik Description and Business Overview 7.9.3 Biomatik Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Biomatik Pulmonary Surfactant Products Offered 7.9.5 Biomatik Recent Development 7.10 Biorbyt 7.10.1 Biorbyt Corporation Information 7.10.2 Biorbyt Description and Business Overview 7.10.3 Biorbyt Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Biorbyt Pulmonary Surfactant Products Offered 7.10.5 Biorbyt Recent Development 7.11 Reddot Biotech 7.11.1 Reddot Biotech Corporation Information 7.11.2 Reddot Biotech Description and Business Overview 7.11.3 Reddot Biotech Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Reddot Biotech Pulmonary Surfactant Products Offered 7.11.5 Reddot Biotech Recent Development 7.12 XpressBio 7.12.1 XpressBio Corporation Information 7.12.2 XpressBio Description and Business Overview 7.12.3 XpressBio Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.12.4 XpressBio Products Offered 7.12.5 XpressBio Recent Development 7.13 Creative Diagnostics 7.13.1 Creative Diagnostics Corporation Information 7.13.2 Creative Diagnostics Description and Business Overview 7.13.3 Creative Diagnostics Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.13.4 Creative Diagnostics Products Offered 7.13.5 Creative Diagnostics Recent Development 7.14 Nanjing Norris Pharm Technology 7.14.1 Nanjing Norris Pharm Technology Corporation Information 7.14.2 Nanjing Norris Pharm Technology Description and Business Overview 7.14.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.14.4 Nanjing Norris Pharm Technology Products Offered 7.14.5 Nanjing Norris Pharm Technology Recent Development 7.15 Windtree Therapeutics 7.15.1 Windtree Therapeutics Corporation Information 7.15.2 Windtree Therapeutics Description and Business Overview 7.15.3 Windtree Therapeutics Pulmonary Surfactant Sales, Revenue and Gross Margin (2017-2022) 7.15.4 Windtree Therapeutics Products Offered 7.15.5 Windtree Therapeutics Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Pulmonary Surfactant Industry Chain Analysis 8.2 Pulmonary Surfactant Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Pulmonary Surfactant Distributors 8.3 Pulmonary Surfactant Production Mode & Process 8.4 Pulmonary Surfactant Sales and Marketing 8.4.1 Pulmonary Surfactant Sales Channels 8.4.2 Pulmonary Surfactant Distributors 8.5 Pulmonary Surfactant Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Pulmonary Surfactant CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Pulmonary Surfactant Market Trends Table 3. Pulmonary Surfactant Market Drivers Table 4. Pulmonary Surfactant Market Challenges Table 5. Pulmonary Surfactant Market Restraints Table 6. Global Pulmonary Surfactant Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Pulmonary Surfactant Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Pulmonary Surfactant Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Pulmonary Surfactant Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Pulmonary Surfactant Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Pulmonary Surfactant Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Pulmonary Surfactant Revenue Share by Manufacturer, 2017-2022 Table 13. Global Pulmonary Surfactant Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Pulmonary Surfactant Sales Share by Manufacturer, 2017-2022 Table 15. Global Pulmonary Surfactant Price by Manufacturer (2017-2022) & (USD/Unit) Table 16. Global Pulmonary Surfactant Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Pulmonary Surfactant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Surfactant as of 2021) Table 18. Top Players of Pulmonary Surfactant in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Pulmonary Surfactant Product Type Table 20. Date of International Manufacturers Enter into Pulmonary Surfactant Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Pulmonary Surfactant Players in United States Market, Ranking by Revenue (2021) Table 23. United States Pulmonary Surfactant Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Pulmonary Surfactant Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Pulmonary Surfactant Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Pulmonary Surfactant Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Pulmonary Surfactant Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Pulmonary Surfactant Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Pulmonary Surfactant Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Pulmonary Surfactant Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Pulmonary Surfactant Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Pulmonary Surfactant Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Pulmonary Surfactant Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Pulmonary Surfactant Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Pulmonary Surfactant Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Pulmonary Surfactant Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Pulmonary Surfactant Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Pulmonary Surfactant Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Pulmonary Surfactant Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Pulmonary Surfactant Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Pulmonary Surfactant Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Boehringer Ingelheim Corporation Information Table 43. Boehringer Ingelheim Description and Business Overview Table 44. Boehringer Ingelheim Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 45. Boehringer Ingelheim Pulmonary Surfactant Product Table 46. Boehringer Ingelheim Recent Development Table 47. AbbVie Corporation Information Table 48. AbbVie Description and Business Overview Table 49. AbbVie Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 50. AbbVie Product Table 51. AbbVie Recent Development Table 52. Lyomark Pharma Corporation Information Table 53. Lyomark Pharma Description and Business Overview Table 54. Lyomark Pharma Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 55. Lyomark Pharma Product Table 56. Lyomark Pharma Recent Development Table 57. Tekzima (Noargen) Corporation Information Table 58. Tekzima (Noargen) Description and Business Overview Table 59. Tekzima (Noargen) Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 60. Tekzima (Noargen) Product Table 61. Tekzima (Noargen) Recent Development Table 62. ONY Biotech Corporation Information Table 63. ONY Biotech Description and Business Overview Table 64. ONY Biotech Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. ONY Biotech Product Table 66. ONY Biotech Recent Development Table 67. Abbott Corporation Information Table 68. Abbott Description and Business Overview Table 69. Abbott Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 70. Abbott Product Table 71. Abbott Recent Development Table 72. Aviva Systems Biology Corporation Information Table 73. Aviva Systems Biology Description and Business Overview Table 74. Aviva Systems Biology Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 75. Aviva Systems Biology Product Table 76. Aviva Systems Biology Recent Development Table 77. LSBio Corporation Information Table 78. LSBio Description and Business Overview Table 79. LSBio Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 80. LSBio Product Table 81. LSBio Recent Development Table 82. Biomatik Corporation Information Table 83. Biomatik Description and Business Overview Table 84. Biomatik Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 85. Biomatik Product Table 86. Biomatik Recent Development Table 87. Biorbyt Corporation Information Table 88. Biorbyt Description and Business Overview Table 89. Biorbyt Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 90. Biorbyt Product Table 91. Biorbyt Recent Development Table 92. Reddot Biotech Corporation Information Table 93. Reddot Biotech Description and Business Overview Table 94. Reddot Biotech Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 95. Reddot Biotech Product Table 96. Reddot Biotech Recent Development Table 97. XpressBio Corporation Information Table 98. XpressBio Description and Business Overview Table 99. XpressBio Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 100. XpressBio Product Table 101. XpressBio Recent Development Table 102. Creative Diagnostics Corporation Information Table 103. Creative Diagnostics Description and Business Overview Table 104. Creative Diagnostics Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 105. Creative Diagnostics Product Table 106. Creative Diagnostics Recent Development Table 107. Nanjing Norris Pharm Technology Corporation Information Table 108. Nanjing Norris Pharm Technology Description and Business Overview Table 109. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 110. Nanjing Norris Pharm Technology Product Table 111. Nanjing Norris Pharm Technology Recent Development Table 112. Windtree Therapeutics Corporation Information Table 113. Windtree Therapeutics Description and Business Overview Table 114. Windtree Therapeutics Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 115. Windtree Therapeutics Product Table 116. Windtree Therapeutics Recent Development Table 117. Key Raw Materials Lists Table 118. Raw Materials Key Suppliers Lists Table 119. Pulmonary Surfactant Customers List Table 120. Pulmonary Surfactant Distributors List Table 121. Research Programs/Design for This Report Table 122. Key Data Information from Secondary Sources Table 123. Key Data Information from Primary Sources List of Figures Figure 1. Pulmonary Surfactant Product Picture Figure 2. Global Pulmonary Surfactant Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Pulmonary Surfactant Market Size 2017-2028 (US$ Million) Figure 4. Global Pulmonary Surfactant Sales 2017-2028 (K Units) Figure 5. United States Pulmonary Surfactant Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Pulmonary Surfactant Market Size 2017-2028 (US$ Million) Figure 7. United States Pulmonary Surfactant Sales 2017-2028 (K Units) Figure 8. United States Pulmonary Surfactant Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Pulmonary Surfactant Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Pulmonary Surfactant Report Years Considered Figure 11. Product Picture of Synthetic Pulmonary Surfactants Figure 12. Product Picture of Animal Derived Surfactants Figure 13. Global Pulmonary Surfactant Market Share by Type in 2022 & 2028 Figure 14. Global Pulmonary Surfactant Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Pulmonary Surfactant Sales Market Share in Value by Type (2017-2028) Figure 16. Global Pulmonary Surfactant Sales by Type (2017-2028) & (K Units) Figure 17. Global Pulmonary Surfactant Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Pulmonary Surfactant Price by Type (2017-2028) & (USD/Unit) Figure 19. United States Pulmonary Surfactant Market Share by Type in 2022 & 2028 Figure 20. United States Pulmonary Surfactant Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Pulmonary Surfactant Sales Market Share in Value by Type (2017-2028) Figure 22. United States Pulmonary Surfactant Sales by Type (2017-2028) & (K Units) Figure 23. United States Pulmonary Surfactant Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Pulmonary Surfactant Price by Type (2017-2028) & (USD/Unit) Figure 25. Product Picture of Hospital Figure 26. Product Picture of laboratory Figure 27. Product Picture of Others Figure 28. Global Pulmonary Surfactant Market Share by Application in 2022 & 2028 Figure 29. Global Pulmonary Surfactant Sales in Value by Application (2017-2028) & (US$ Million) Figure 30. Global Pulmonary Surfactant Sales Market Share in Value by Application (2017-2028) Figure 31. Global Pulmonary Surfactant Sales by Application (2017-2028) & (K Units) Figure 32. Global Pulmonary Surfactant Sales Market Share in Volume by Application (2017-2028) Figure 33. Global Pulmonary Surfactant Price by Application (2017-2028) & (USD/Unit) Figure 34. United States Pulmonary Surfactant Market Share by Application in 2022 & 2028 Figure 35. United States Pulmonary Surfactant Sales in Value by Application (2017-2028) & (US$ Million) Figure 36. United States Pulmonary Surfactant Sales Market Share in Value by Application (2017-2028) Figure 37. United States Pulmonary Surfactant Sales by Application (2017-2028) & (K Units) Figure 38. United States Pulmonary Surfactant Sales Market Share in Volume by Application (2017-2028) Figure 39. United States Pulmonary Surfactant Price by Application (2017-2028) & (USD/Unit) Figure 40. North America Pulmonary Surfactant Sales in Volume Growth Rate 2017-2028 (K Units) Figure 41. North America Pulmonary Surfactant Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 42. U.S. Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 43. Canada Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Europe Pulmonary Surfactant Sales in Volume Growth Rate 2017-2028 (K Units) Figure 45. Europe Pulmonary Surfactant Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 46. Germany Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. France Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. U.K. Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Italy Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Russia Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Asia-Pacific Pulmonary Surfactant Sales in Volume Growth Rate 2017-2028 (K Units) Figure 52. Asia-Pacific Pulmonary Surfactant Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 53. China Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Japan Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. South Korea Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. India Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. Australia Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Taiwan Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Indonesia Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Thailand Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Malaysia Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Philippines Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Latin America Pulmonary Surfactant Sales in Volume Growth Rate 2017-2028 (K Units) Figure 64. Latin America Pulmonary Surfactant Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 65. Mexico Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Brazil Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Argentina Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Middle East & Africa Pulmonary Surfactant Sales in Volume Growth Rate 2017-2028 (K Units) Figure 69. Middle East & Africa Pulmonary Surfactant Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 70. Turkey Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. Saudi Arabia Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. U.A.E Pulmonary Surfactant Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. Pulmonary Surfactant Value Chain Figure 74. Pulmonary Surfactant Production Process Figure 75. Channels of Distribution Figure 76. Distributors Profiles Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed

Boehringer Ingelheim AbbVie Lyomark Pharma Tekzima (Noargen) ONY Biotech Abbott Aviva Systems Biology LSBio Biomatik Biorbyt Reddot Biotech XpressBio Creative Diagnostics Nanjing Norris Pharm Technology Windtree Therapeutics